叶酸强化和晚发性结直肠癌风险:全球证据的系统评估
Tongtong Li1, Yuan Li1, Lina Yin2
1Department of Nutrition and Food Science, School of Public Health, Tianjin Medical University, Tianjin, China.
International journal of cancer
|August 25, 2025
概括
强制补充叶酸与晚期结直肠癌 (LOCRC) 的发病率较低有关. 全球分析显示,在强化政策后,LOCRC的发病率下降,支持其在癌症预防中的作用.
科学领域:
- 公共卫生
- 营养流行病学
- 预防癌症
背景情况:
- 叶酸强化政策在全球范围内有所不同,关于潜在的健康影响仍在进行争论.
- 结肠直肠癌仍然是一个重要的全球健康问题,特别是晚期发病的形式.
- 了解叶酸强化与癌症发病率之间的关系对于公共卫生政策至关重要.
研究的目的:
- 调查强制性叶酸强化政策与晚发性结肠直肠癌 (LOCRC) 发生率之间的全球联系.
- 在强制增添叶酸和不强制增添叶酸的国家比较LOCRC发病率.
- 分析叶酸强化之前和之后的发病趋势.
主要方法:
- 世界卫生组织193个成员国的叶酸强化政策的系统评估.
- 根据国家对年龄标准化的LOCRC发病率的分析.
- 生态研究设计检查强化类型和LOCRC发病率之间的关联,用于趋势分析的结合点回归.
主要成果:
- 69个国家有强制性叶酸强化; 124个国家没有.
- 在强制强化国家,LOCRC的发病率为每10万人中70.8,而在非强化国家为84.0.
- 在美国和加拿大,强化后的LOCRC发病率趋势与强化前的时期相比出现了更快的下降.
结论:
- 强制性叶酸强化政策与晚期结直肠癌发生率的降低有关.
- 全球数据支持叶酸强化作为预防癌症的战略.
- 这些发现为公众健康强化政策提供了科学基础.
相关概念视频
Cancer Prevention
6.3K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.3K
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
419
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
419
Mutagenicity and Carcinogenicity
1.4K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.4K
Teratogenicity
2.7K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.7K
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
687
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
687
Drugs for Treatment of Ulcerative Colitis in IBD
236
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
236


